Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Curves01:18

Survival Curves

99
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
99
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

146
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
146
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

95
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
95
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

90
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
90
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

348
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
348

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lavandin cell extract enriched in rosmarinic acid attenuates inflammation via AMPK/Nrf2/HO-1 activation and IKK/IκB/NF-κB inhibition.

BMC plant biology·2026
Same author

Avoid All the Competitive Ones: Dynamics of Altruistic Behavior, Mediators, and Moderators in an Evacuation Drill.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma.

Transplantation and cellular therapy·2026
Same author

A ratiometric fluorescent reporter of mitochondrial sodium.

Nature chemical biology·2026
Same author

STAT6 inhibition of M2 macrophages suppresses tumor growth by modulating the tumor microenvironment in colon cancer model.

Frontiers in immunology·2026
Same author

Antioxidant Supplementation with Caffeine During Rescue In Vitro Maturation Improves Fertilization and Embryo Development in Women of Advanced Maternal Age.

Antioxidants (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jun 3, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211

Adjusted curves for clustered survival and competing risks data.

Manoj Khanal1, Soyoung Kim1, Kwang Woo Ahn1

  • 1Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Communications in Statistics: Simulation and Computation
|January 10, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces methods for adjusted survival and cumulative incidence curves in clustered right-censored data. The new R package adjSURVCI provides unbiased estimates for improved clinical trial analysis.

Keywords:
Adjusted curvesClustered right-censored dataCox proportional hazards modelProportional subdistribution hazards modelR Package adjSURVCI

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 3, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

211
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Trials

Background:

  • Observational studies with right-censored data often exhibit clustering (e.g., matched pairs, study centers).
  • Clustered data can lead to patient characteristic imbalances between treatment groups.
  • Unadjusted survival or cumulative incidence curves (e.g., Kaplan-Meier) can be misleading in such scenarios.

Purpose of the Study:

  • To propose and implement methods for estimating adjusted survival and cumulative incidence probabilities for clustered right-censored data.
  • To account for both covariate-independent and covariate-dependent censoring in competing risks outcomes.
  • To provide a user-friendly R package for applying these advanced statistical methods.

Main Methods:

  • Development of novel statistical methods for adjusted survival and cumulative incidence estimation in clustered right-censored data.
  • Incorporation of flexibility to handle competing risks with various censoring types.
  • Implementation of these methods within the R package 'adjSURVCI'.

Main Results:

  • Simulation studies demonstrate that the proposed methods yield unbiased estimates for adjusted survival and cumulative incidence probabilities.
  • The methods achieve approximate 95% coverage rates in simulations.
  • The developed R package 'adjSURVCI' successfully applies these methods to real-world data, such as stem cell transplant outcomes.

Conclusions:

  • The proposed methods effectively provide adjusted survival and cumulative incidence probabilities for clustered right-censored data.
  • The 'adjSURVCI' R package offers a reliable tool for researchers dealing with complex survival data.
  • Accurate survival analysis is crucial for interpreting clinical trial results, especially in the presence of clustering and competing risks.